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Abstract
Background: The relative contributions of genetics and environment to asthma in Hispanics or to asthma in children
younger than 3 years are not well understood.
Objective: To examine the relative contributions of genetics and environment to early-childhood asthma by performing a
longitudinal twin study of asthma in Puerto Rican children #3 years old.
Methods: 678 twin infants from the Puerto Rico Neo-Natal Twin Registry were assessed for asthma at age 1 year, with
follow-up data obtained for 624 twins at age 3 years. Zygosity was determined by DNA microsatellite profiling. Structural
equation modeling was performed for three phenotypes at ages 1 and 3 years: physician-diagnosed asthma, asthma
medication use in the past year, and $1 hospitalization for asthma in the past year. Models were additionally adjusted for
early-life environmental tobacco smoke exposure, sex, and age.
Results: The prevalences of physician-diagnosed asthma, asthma medication use, and hospitalization for asthma were
11.6%, 10.8%, 4.9% at age 1 year, and 34.1%, 40.1%, and 8.5% at 3 years, respectively. Shared environmental effects
contributed to the majority of variance in susceptibility to physician-diagnosed asthma and asthma medication use in the
first year of life (84%–86%), while genetic effects drove variance in all phenotypes (45%–65%) at age 3 years. Early-life
environmental tobacco smoke, sex, and age contributed to variance in susceptibility.
Conclusion: Our longitudinal study in Puerto Rican twins demonstrates a changing contribution of shared environmental
effects to liability for physician-diagnosed asthma and asthma medication use between ages 1 and 3 years. Early-life
environmental tobacco smoke reduction could markedly reduce asthma morbidity in young Puerto Rican children.
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Introduction
Twin studies offer a unique opportunity to examine the relative
contributions of genetic and environmental factors to childhood
asthma. Monozygotic twins completely share their genetics and
early-life environment, while dizygotic twins share only half their
genetics and all their early-life environment. Early twin studies of
asthma concluded that the environment exerted stronger effects
than genetics.[1,2] These findings were consistent with epidemi-
ologic studies demonstrating a role for environmental factors such
as tobacco smoke in asthma pathogenesis.[3,4]
Recent twin studies of asthma argue that genetic factors
primarily explain asthma susceptibility,[5–7] and that shared
environmental factors do not contribute to its variation.[8] In this
study, we assess the relative contributions of genetics and
environment to asthma susceptibility and its variation with age
by conducting a longitudinal twin study of asthma starting in
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infancy. To our knowledge, this is the first twin study to examine
asthma at such an early age. [8–13]
Most twin studies of asthma have been conducted in Caucasian
adults.[14] Since candidate gene and genome-wide association
studies have demonstrated ethnic-specific genetic effects for
asthma (e.g. in Hispanic subgroups),[15,16] and studies of
environmental risk factors for asthma have also identified ethnic-
specific results,[17] twin studies could also yield ethnic-specific
findings for the genetic and environmental contributions to
childhood asthma. We report the first twin study of asthma in
Puerto Ricans, a Hispanic subgroup with the highest prevalence of
childhood asthma among U.S. ethnic groups.[18–20]
Methods
Population
All families with multiple gestation pregnancy in Puerto Rico in
2006 were considered for inclusion. Contact information was
obtained from the Puerto Rico Neonatal Twin Registry with
assistance from the Puerto Rico Department of Health. Families
were contacted within 3 months of birth and were not selected for
any disease. Of the 481 families with multiple births, 82 were
ineligible (Figure 1). Of the 399 eligible families, 339 (85%)
families with twins elected to participate. At age 1 year, parents
answered questionnaires addressing demographics, asthma, in utero
smoke (IUS) exposure, and environmental tobacco smoke (ETS).
Parents were recontacted when the children were age 3 years, with
312 (92%) of the original 339 families completing follow-up
questionnaires. Questions regarding ETS exposure were not
repeated at age 3 years. Written informed consent was obtained
from all study participants, including parents on the behalf of
children participants. The study was approved by the Institutional
Review Boards of the University of Puerto Rico and Virginia
Commonwealth University (IRB#4774).
Outcomes
For each twin, outcomes assessed at 1 and 3 years of age
included parental report of physician-diagnosed asthma, asthma
medication use in the past year, and any hospitalization for asthma
in the past year. Specifically, study staff asked parents, ‘‘Has (name
of child) ever been diagnosed by a doctor as having asthma.’’
Asthma medication use in the past year was classified as positive if
a parent answered yes to either of these two questions: ‘‘Has (name
of child) used any prescribed asthma medications in the last 12
months,’’ and ‘‘During the last 12 months, has (name of child) had
any oral steroids (eg. prednisone burst, prelone)?’’ A child was
considered to have had a hospitalization for asthma in the past
year if a parent answered yes to ‘‘During the last 12 months, has
(name of child) been hospitalized for asthma?’’
Zygosity
Zygosity was assessed by questionnaire and DNA testing.
Parents were asked if their twins were identical or fraternal.
Although self-reported zygosity has been shown to be adequate in
95–98% of cases,[21] we sought to maximize the accuracy of our
zygosity classification with DNA testing. We collected saliva from
292 participating twin pairs (584 subjects) for DNA extraction and
genotyping of 47 independent microsatellite markers. Subjects
with uniformly concordant microsatellite calls were considered
monozygotic by DNA testing. The agreement rate between
parental-reported zygosity and DNA testing was assessed using
the Kappa statistic and measures of sensitivity and specificity. The
DNA results served as our gold-standard for zygosity determina-
tion.
Statistical Analysis
Probandwise concordance rates were calculated for monozy-
gotic and dizygotic twins for each phenotype according to
standard methods.[22]
To estimate the contributions of genetic and environmental risk
factors to susceptibility to asthma phenotypes at ages 1 and 3
years, we fitted structural equation models to estimate variance
components using Mx (Figure 2).[23] Mx is a matrix algebra
interpreter and numerical optimizer frequently used in the analysis
of twin data. Standard models within twin research assume that
susceptibility to outcomes are a linear function of additive genetic
effects [A], shared environmental effects [C], and nonshared
random environmental effects [E].[23] The tetrachoric correlation
is used in twin analyses as a standard measure of correlation or
agreement between binary variables. The tetrachoric correlation
among monozygotic twins (rMZ) =A+C, and the tetrachoric
correlation among dizygotic twins (rDZ) =K A+C.[23]
Based on covariances estimated from tetrachoric correlations,
univariate models were created with A, C, and E latent sources of
variance.[23] To assess for possible effect modification by sex, we
created sex-stratified models (allowing for different male and
female estimates) for each phenotype and compared them by
likelihood ratio x2 test to the corresponding unstratified model.
Models incorporating covariates for sex, age, and early-life ETS
were then created. These adjusted models were compared to
univariate models by likelihood ratio x2 tests to decipher potential
contributors to detected environmental variances. These covari-
ates were chosen a priori given previous epidemiologic data.
Specifically, male sex and younger age are known risk factors for
asthma in early childhood.[24,25] With regard to ETS, (1) Puerto
Rican women have the highest rate of perinatal smoking among all
Figure 1. Study design of the Puerto Rico Neo-Natal Twin
Registry.
doi:10.1371/journal.pone.0068473.g001
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U.S. Hispanics (9.2% prevalence),[26] (2) ETS demonstrated a
significant effect on hospitalizations for asthma at age 1 year in this
cohort,[27] and (3) IUS has been associated with asthma in Puerto
Ricans.[28] Early-life ETS exposure was defined as either IUS or
ETS exposure in the first year.
Results
The phenotypic characteristics of children in the Puerto Rico
Neonatal Twin Registry at ages 1 and 3 years are shown in
Table 1. Although the rates of zygosity by parental report and
DNA testing were equal, this did not result from identical zygosity
calls for each twin pair between the methods. There was 88.3%
agreement between parental-reported zygosity and DNA testing
(Kappa statistic 0.74 (95% CI=0.6620.82)). Parental-reported
zygosity had 82.5% sensitivity and 91.5% specificity for zygosity
by DNA testing. There was no significant difference in socioeco-
nomic status between monozygotic and dizygotic twin pairs.
A substantial minority of twins experienced early-life ETS
(Table 1). From age 1 year to age 3 years, the prevalence of
physician-diagnosed asthma nearly tripled, asthma medication use
in the past year nearly quadrupled, and the prevalence of $1
hospitalization for asthma in the past year nearly doubled. The
proportions of children who had each of the outcomes of interest
at both age 1 year and age 3 years were 8.8% for physician-
diagnosed asthma, 7.5% for asthma medication use in the past
year, and 1.3% for $1 hospitalization for asthma in the past year.
Table 2 shows the prevalence and resemblance between twins
for asthma-related phenotypes at age 1 year. Probandwise
concordance was slightly lower for dizygotic subjects relative to
monozygotic subjects for each of these phenotypes. Accordingly,
tetrachoric correlations were lower for dizygotic subjects.
Table 3 shows the prevalence and resemblance between twins
for asthma-related phenotypes at age 3 years. Probandwise
concordance and tetrachoric correlations were again lower for
dizygotic subjects compared to monozygotic subjects for each of
these phenotypes.
Variance components from structural equation modeling of
asthma-related phenotypes at age 1 year are shown in Table 4.
Genetic factors accounted for 11% (A), and shared environmental
effects accounted for 84% to 86% (C) of the variance in
susceptibility to physician-diagnosed asthma and asthma medica-
tion use in the past year. There was no significant effect of sex
stratification on model fit for any phenotype at age 1 year (Table
S1 in File S1). Sex-adjusted models for physician-diagnosed
asthma and asthma medication use were not significantly different
from the corresponding unadjusted models (Table 4). However,
models for asthma medication use that were additionally adjusted
for early-life ETS and age significantly differed from unadjusted
models (P value ,0.001), suggesting that early-life ETS and age
may contribute to shared environmental effects in asthma
medication use. Early-life ETS exposure and older age were
associated with asthma medication use, and older age was
associated with physician-diagnosed asthma.
In contrast to our findings for physician-diagnosed asthma and
asthma medication use, genetic factors accounted for almost all of
variance in susceptibility to hospitalization for asthma among all
twins (A= 0.95). Notwithstanding, multivariate models with sex,
early-life ETS, and age adjustments yielded models with signifi-
cantly better fit and higher C estimates, supporting that sex, early-
life ETS, and age all contribute to shared environmental effect in
variance to susceptibility to hospitalizations for asthma.
Variance components from structural equation modeling of
asthma-related phenotypes at age 3 years are shown in Table 5.
In contrast to the results at age 1 year, genetic factors accounted
for a substantial proportion (45%–65%) of the unadjusted variance
in susceptibility to all three phenotypes at age 3 years. There was
no significant effect of sex stratification on model fit for any
phenotype at age 3 years (Table S2 in File S1). Adjustments for
Figure 2. ACE model for calculating genetic and environmental
influence from twin correlations.[23]
doi:10.1371/journal.pone.0068473.g002
Table 1. Characteristics of participants at ages 1 and 3 years.
Characteristic Age 1 year (n =678) Age 3 years (n =624)
Female 352 (51.9%) 328 (52.6%)
Monozygotic 240 (35.4%) 206 (35.3%)*
Physician-diagnosed asthma 78 (11.6%) 213 (34.1%)
Asthma medication use in past 12 months 73 (10.8%) 250 (40.1%)
Hospitalized for asthma in past 12 months 33 (4.9%) 53 (8.5%)
Intrauterine smoke exposure 20 (3%)
Environmental tobacco smoke exposure‘ 94 (13.9%)
Values are reported as number (%) or mean (SD).
*By DNA testing available for 584 subjects (292 twin pairs)); prevalence per parental report for 678 subjects at 1yo was the same (240 (35.4%)).
‘Defined as cigarette smoke exposure $2 times/week in first year of life.
doi:10.1371/journal.pone.0068473.t001
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sex and age resulted in models with better fit for all phenotypes
(Table 5), with male sex and older age positively associated with
the outcomes. Adjustment for early-life ETS did not significantly
alter model fit. The substantial genetic contribution to variance in
susceptibility to all three phenotypes remained evident in the
adjusted models and ranged from 34% to 59%.
Structural equation models of asthma-related phenotypes
persisting between ages 1 and 3 years (e.g. reported asthma
medication use at both ages) were unstable due to low prevalence
of these outcomes; the results from these particular models are
therefore not shown.
Discussion
The diagnosis of asthma is challenging before age 6 years.[29]
Although wheeze occurs in approximately one third of children
before age 3 years, ,59% of children who wheeze before age 3
years will have no wheeze by age 6 years (‘‘transient wheeze’’).[25]
Because it is difficult to predict whether a wheezing infant will
have transient vs. persistent wheeze,[30] physicians may be less
likely to diagnose asthma at age 1 year than at age 3 years. This
would partly explain our finding of a higher prevalence of asthma-
related outcomes at age 3 years than at age 1 year.
A large proportion of children diagnosed with asthma or
receiving medications for asthma at age 1 year may have transient
wheeze. Early-life ETS and viral infection are risk factors for
transient wheeze,[25,30] and these exposures would be shared
between twins. This would explain why we observed that shared
environmental effects contributed ,85% to susceptibility to
physician-diagnosed asthma and asthma medication use in the
first year of life.
In contrast, physician-diagnosed asthma or asthma medication
use at age 3 years may be less likely to be due to viral illnesses and
more likely to represent ‘‘true asthma’’. Risk factors for wheeze
persisting at or after age 3 years include atopy and a history of
maternal asthma, [25] which have a recognized genetic basis.
Consistent with this, we observed that physician-diagnosed asthma
had a more significant genetic component at age 3 years than at
age 1 year.
Unlike physician-diagnosed asthma or asthma medication use, a
hospitalization for asthma signals a more severe manifestation of
asthma. Severe asthma may represent a phenotype distinct from
mild or moderate asthma.[31] and often manifests in children in
the first 24 months of life.[30] Severe asthma has been associated
with more symptoms, greater airway obstruction, increased
bronchial responsiveness to methacholine, higher F(ENO) and
Table 2. Prevalence and resemblance between twins for asthma-related phenotypes at age 1 year.
Phenotype Pairs* Cases
Discordant
pairs
Concordant
pairs
Probandwise
concordance
Tetrachoric
correlation (95% CI)
Physician-diagnosed asthma
MZ 101 24 4 97 0.980 0.97 (0.91–1.00)
DZ 188 43 12 176 0.967 0.92 (0.84–1.00)
Asthma medications use in past 12 months
MZ 103 25 5 98 0.975 0.96 (0.88–1.00)
DZ 189 38 13 176 0.964 0.89 (0.77–1.00)
Hospitalized for asthma in past 12 months
MZ 102 13 3 99 0.985 0.96 (0.87–1.00)
DZ 187 17 13 174 0.964 0.53 (0.11–0.96)
MZ= monozygotic, DZ = dizygotic.
*584 subjects with zygosity confirmed by DNA testing were used in this analysis.
doi:10.1371/journal.pone.0068473.t002
Table 3. Prevalence and resemblance between twins for asthma-related phenotypes at age 3 years.
Phenotype Pairs* Cases
Discordant
pairs
Concordant
pairs
Probandwise
concordance
Tetrachoric
correlation (95% CI)
Physician-diagnosed asthma
MZ 102 84 10 92 0.948 0.95 (0.90–1.00)
DZ 189 117 49 140 0.851 0.61 (0.43–0.78)
Asthma medications use in past 12 months
MZ 102 90 10 92 0.948 0.95 (0.80–1.00)
DZ 189 144 48 141 0.855 0.67 (0.52–0.82)
Hospitalized for asthma in past 12 months
MZ 102 23 7 95 0.964 0.91 (0.78–1.00)
DZ 189 29 19 170 0.947 0.58 (0.28–0.88)
MZ= monozygotic, DZ = dizygotic.
*584 subjects with zygosity confirmed by DNA testing were used in this analysis.
doi:10.1371/journal.pone.0068473.t003
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greater sensitization to aeroallergens.[31] These risk factors reflect
intrinsic characteristics that are more likely to be genetically rather
than environmentally determined. The relative age-independency
of our findings for a genetic contribution to asthma-related
hospitalizations is consistent with these characteristics of severe
asthma.
Our results suggest that ETS (an exposure that would be shared
by twins in a given pair) partly explains the estimated effects of
shared environmental factors on medication use for asthma at age
1 year. ETS has been more strongly associated with asthma
susceptibility during early life[32] than in later childhood.[33] A
recent study conducted in a hundred infants’ homes with 68%
prevalence of ETS demonstrated that elevated levels of particulate
matter increased the odds of wheezing in the first year of life by
over fourfold, and elevated levels of the nicotine metabolite
cotinine in infant urine increased the odds of wheezing by over
fivefold.[32] In contrast, a study of 126 children ages 6–12 years
(where 68% of primary caregivers smoked in the home) showed
that ETS exposure, as measured by high air nicotine and
particulate matter levels, was not associated with asthma
symptoms.[33] Consistent with these findings that ETS may have
less effect on asthma susceptibility in later childhood compared to
infancy, adjustment for ETS did not significantly alter variance
component models of asthma-related outcomes at age 3 years.
Although ours is the first twin study of asthma to examine
longitudinal data from infancy and early childhood, it is not the
first to report age-dependent findings for heritability. A study of
Danish twins ages 3–71 years demonstrated that the relative
Table 4. Variance component analysis of asthma-related phenotypes at age 1 year.
Phenotype A# (95% CI) C (95% CI) E (95% CI) P value*
Physician-diagnosed asthma 0.11 (0.00–0.37) 0.86 (0.60–0.97) 0.03 (0.003–0.13)
Adjusted for sex 0.09 (0.00–0.34) 0.88 (0.64–0.98) 0.03 (0.003–0.13) 0.06
Adjusted for sex and early-life ETS‘ 0.09 (0.00–0.34) 0.88 (0.64–0.98) 0.03 (0.003–0.13) 0.06
Adjusted for sex and age 0.11 (0.11–0.12) 0.86 (0.83–0.86) 0.03 (0.03–0.05) ,0.001
Asthma medication use in past 12 months 0.11 (0.00–0.43) 0.84 (0.54–0.97) 0.05 (0.01–0.16)
Adjusted for sex 0.09 (0.00–0.39) 0.86 (0.58–0.97) 0.05 (0.01–0.16) 0.12
Adjusted for sex and early-life ETS 0.09 (0.00–0.40) 0.86 (0.56–0.97) 0.05 (0.01–0.17) ,0.001
Adjusted for sex and age 0.11 (0.11–0.14) 0.84 (0.78–0.84) 0.05 (0.05–0.09) ,0.001
Hospitalized for asthma in past 12 months 0.95 (0.12–0.99) 0.0004 (0.00–0.74) 0.05 (0.003–0.26)
Adjusted for sex 0.55 (0.00–0.99) 0.40 (0.00–0.91) 0.05 (0.004–0.28) ,0.001
Adjusted for sex and early-life ETS 0.59 (0.00–0.99) 0.35 (0.00–0.90) 0.06 (0.004–0.31) ,0.001
Adjusted for sex and age 0.70 (0.001–0.99) 0.24 (0.00–0.24) 0.06 (0.06–0.11) ,0.001
584 subjects with zygosity confirmed by DNA testing were used in these models.
#A= additive genetic variance, C = shared environmental variance, E = non-shared environmental variance [23].
*P-value for likelihood ratio x2 test comparing adjusted to univariate model.
‘Early-life environmental tobacco smoke (ETS) defined as intrauterine smoke exposure or cigarette exposure $26/week during the first year of life.
doi:10.1371/journal.pone.0068473.t004
Table 5. Variance component analysis of asthma-related phenotypes at age 3 years.
Phenotype A#(95% CI) C (95% CI) E (95% CI) P value*
Physician-diagnosed asthma 0.65 (0.31–0.97) 0.29 (0.00–0.59) 0.06 (0.02–0.16)
Adjusted for sex 0.57 (0.24–0.96) 0.37 (0.00–0.66) 0.06 (0.02–0.16) ,0.001
Adjusted for sex and early-life ETS‘ 0.57 (0.23–0.96) 0.37 (0.00–0.66) 0.06 (0.02–0.16) 0.11
Adjusted for sex and age 0.59 (0.59–0.61) 0.35 (0.27–0.35) 0.06 (0.06–0.12) 0.03
Asthma Medications in past 12 months 0.45 (0.15–0.80) 0.52 (0.17–0.77) 0.03 (0.005–0.14)
Adjusted for sex 0.34 (0.05–0.66) 0.63 (0.31–0.85) 0.03 (0.005–0.15) ,0.001
Adjusted for sex and early-life ETS‘ 0.34 (0.05–0.67) 0.62 (0.31–0.85) 0.04 (0.005–0.15) 0.23
Adjusted for sex and age 0.37 (0.37–0.37) 0.60 (0.57–0.60) 0.04 (0.04–0.04) ,0.001
Hospitalized for asthma in past 12 months 0.56 (0.00–0.97) 0.33 (0.00–0.82) 0.11 (0.02–0.33)
Adjusted for sex 0.57 (0.00–0.97) 0.32 (0.00–0.82) 0.11 (0.02–0.33) 0.09
Adjusted for sex and early-life ETS‘ 0.59 (0.00–0.97) 0.30 (0.00–0.81) 0.11 (0.03–0.32) 0.10
Adjusted for sex and age 0.59 (0.00–0.97) 0.30 (0.00–0.91) 0.11 (0.03–0.32) 0.01
584 subjects with zygosity confirmed by DNA testing were used in these models.
#A= additive genetic variance, C = shared environmental variance, E = non-shared environmental variance.[23].
*P-value for likelihood ratio x2 test comparing adjusted model to univariate model.
‘Early-life environmental tobacco smoke (ETS) defined as intrauterine smoke exposure or cigarette exposure $26/week during the first year of life.
doi:10.1371/journal.pone.0068473.t005
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importance of environmental factors on asthma susceptibility
increased over lifespan.[14] This study grouped twins into three
age groups: 3–20, 20–49, and 50–71 years. Their study did not
include children younger than 3 years, however, and it is possible
that a strong role for shared environmental factors to asthma
susceptibility would have been observed had they analyzed
subjects during infancy.
Regardless of potential misclassification of transient wheeze as
physician-diagnosed asthma in young twins, our findings and those
of others[34,35] support public health interventions to reduce ETS
exposure to decrease asthma and viral-induced wheeze, two causes
of significant morbidity in early childhood. ETS is associated with
up to 12-fold higher odds of asthma-related hospitalization in
children and adults.[36,37] A study of over 21,000 hospitalizations
for asthma in children demonstrated that reduction in ETS is
associated with decreased asthma-related hospitalizations.[34]
The protective effect of ETS reduction on asthma morbidity is
particularly relevant to individuals of Puerto Rican origin or
ancestry, who not only share disproportionate burdens from
asthma[18–20,38] and perinatal smoking,[26] but who are also at
risk for smoking cessation failure.[39] Consistent with our study,
early-life ETS has been associated with asthma in Puerto
Ricans.[28,40] Previous estimates show that ETS avoidance could
reduce the likelihood of severe asthma in Puerto Ricans by almost
half.[35]
Our study contributes the first twin study of asthma in Hispanics
to the asthma literature. Less information about asthma exists for
Hispanics than for any other ethnic group in the United States,
despite the fact that Hispanics are the largest and fastest growing
minority group in the US and have high rates of morbidity from
asthma.[41] Compared to other ethnic groups with asthma,
Hispanics experience higher mortality[42] and morbidity,[43]
with Puerto Ricans ranking highest. The environmental and
genetic risk factors underlying asthma in Hispanics are also distinct
from those for other ethnic populations.[16,43] Therefore, twin
studies of asthma in Hispanic populations, and Puerto Ricans in
particular, can be highly informative and impactful, as they
provide the opportunity to simultaneously examine genetic and
environmental contributions to asthma in a population that suffers
from asthma distinctly and disproportionately.
We recognize several limitations of our study. Firstly, we did not
obtain objective measures of asthma severity or lung function.
While this has been done in twin studies of older children and
adults,[7,9] it was impractical in our study participants, all of
whom were younger than 4 years. To reduce the impact of
diagnostic bias in young children, we analyzed not only physician-
diagnosed asthma but also medication use and hospitalizations for
asthma. This is reasonable in infants and young children, and
preferable to sole reliance on self-reported asthma (a common
approach in prior twin studies).[14] Secondly, there could be a
tendency to over-diagnose or over-treat asthma in the second
member of a twin pair if the first member had been diagnosed or
treated for asthma. However, this should not markedly differ
between pairs of MZ twins and pairs of DZ twins, and would have
thus biased our results toward the null hypothesis.
Thirdly, a relatively low number of study participants had
persistence of the outcomes (e.g. physician-diagnosed asthma)
from age 1 year to age 3 years, and we thus had limited statistical
power to examine the heritability of these sub-phenotypes.
However, we had adequate power for our primary analysis of
the heritability for asthma-related outcomes at age 1 year and at
age 3 years. Fourthly, we lacked data on shared environmental
exposures other than ETS (e.g. viral infections, allergen exposure).
Conclusions
Among Puerto Rican children, shared environmental factors
highly contribute to variance in susceptibility to physician-
diagnosed asthma and need for asthma medication at age 1 year,
while genetic factors contributed strongly to variation in these
phenotypes at age 3 years. Early-life ETS partly explained shared
environmental effects for medication use or hospitalizations for
asthma at age 1 year. Early-life environmental tobacco smoke
reduction could markedly reduce asthma morbidity in young
Puerto Rican children.
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